Page last updated: 2024-08-26

5-chloro-2'-deoxycytidine and Fibrosarcoma

5-chloro-2'-deoxycytidine has been researched along with Fibrosarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gottlieb, C; Greer, S; Marion, HS; Santos, O; Schwade, J1

Other Studies

1 other study(ies) available for 5-chloro-2'-deoxycytidine and Fibrosarcoma

ArticleYear
5-chlorodeoxycytidine, a radiosensitizer effective against RIF-1 and Lewis lung carcinoma, is also effective against a DMBA-induced mammary adenocarcinoma and the EMT-6 tumor in BALB/c mice.
    International journal of radiation oncology, biology, physics, 1992, Volume: 22, Issue:3

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Animals; Combined Modality Therapy; Deoxycytidine; Fibrosarcoma; Lung Neoplasms; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Neoplasms, Experimental; Neoplasms, Radiation-Induced; Radiation-Sensitizing Agents

1992